How United States Clinical Research Companies Can Have A China Strategy Drug Approvals

Research in the US is conducted differently in other countries and China is no exception. However, US companies are beginning to learn that the Chinese market is not impossible to enter. The guest in this video explains what steps US pharmaceutical companies can take to adhere to Chinese regulations and obtain approval for proper entry into the Chinese market.

Guest UserComment